A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain Publication A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain The level of the endocannabinoid anandamide is controlled by fatty acid amide hydrolase (FAAH). In…Certara2014 年 1 月 15 日
The IQ-CSRC Prospective Clinical Phase 1 Study: Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study? 刊物 The IQ-CSRC Prospective Clinical Phase 1 Study: Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study? A collaboration between the Consortium for Innovation and Quality in Pharmaceutical Development and the Cardiac…Certara2014 年 1 月 1 日
Incorporating Target Shedding into a Minimal PBPK-TMDD Model for Monoclonal Antibodies Publication Incorporating Target Shedding into a Minimal PBPK-TMDD Model for Monoclonal Antibodies Shedding of a pharmacological target from cells, giving rise to a soluble target that can also bind therapeutic proteins, is…Certara2014 年 1 月 1 日
Anatomical, Physiological and Metabolic Changes with Gestational Age During Normal Pregnancy: A Database for Parameters Required in Physiologically-based Pharmacokinetic Modeling Publication Anatomical, Physiological and Metabolic Changes with Gestational Age During Normal Pregnancy: A Database for Parameters Required in Physiologically-based Pharmacokinetic Modeling Pregnancy is associated with considerable changes in the physiological, anatomical and biochemical attributes in women.…Certara2013 年 12 月 13 日
Bottom-up Modeling and Simulation of Tacrolimus Clearance: Prospective Investigation of Blood Cell Distribution, Sex and CYP3A5 Expression as Covariates and Assessment of Study Power Publication Bottom-up Modeling and Simulation of Tacrolimus Clearance: Prospective Investigation of Blood Cell Distribution, Sex and CYP3A5 Expression as Covariates and Assessment of Study Power The objectives were to investigate the ability of population-based in vitro-in vivo extrapolation (IVIVE) to…Certara2013 年 12 月 1 日
An Evaluation of the Pharmacokinetics of Treprostinil Diethanolamine in Subjects with Hepatic Impairment Publication An Evaluation of the Pharmacokinetics of Treprostinil Diethanolamine in Subjects with Hepatic Impairment Treprostinil diolamine (oral treprostinil) is a prostacyclin analogue under evaluation for the treatment for pulmonary…Certara2013 年 12 月 1 日
Modeling of Pharmacokinetic Systems Using Stochastic Deconvolution Publication Modeling of Pharmacokinetic Systems Using Stochastic Deconvolution In environments where complete mechanistic knowledge of the system dynamics is not available, a synergy…Certara2013 年 12 月 1 日
Differences in Cytochrome P450-mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically-based Pharmacokinetic Modeling Publication Differences in Cytochrome P450-mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically-based Pharmacokinetic Modeling International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)…Certara2013 年 12 月 1 日
Absence of Pharmacokinetic Drug-drug Interaction of Pertuzumab with Trastuzumab and Docetaxel Publication Absence of Pharmacokinetic Drug-drug Interaction of Pertuzumab with Trastuzumab and Docetaxel Pertuzumab is a novel antihuman epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody. Combined…Certara2013 年 11 月 24 日
Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis On-Demand Webinar Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis Are you currently using Excel for PK/TK analysis? Phoenix WinNonlin streamlines analyses and generates all…Certara2013 年 11 月 21 日